Identification of pathogens by comprehensive real-time PCR versus conventional methods in community-acquired pneumonia in Japanese adults

Infectious Diseases

Volumn 48, Issue 11-12, 2016, Pages 782-788

  Yoshii, Yutaka ^a   Shimizu, Kenichiro ^a   Morozumi, Miyuki ^b   Chiba, Naoko ^b   Ubukata, Kimiko ^b   Uruga, Hironori ^c   Hanada, Shigeo ^c   Wakui, Hiroshi ^a   Ito, Saburo ^a   Takasaka, Naoki ^a   Minagawa, Shunsuke ^a   Kojima, Jun ^a   Numata, Takanori ^a   Hara, Hiromichi ^a   Kawaishi, Makoto ^a   Saito, Keisuke ^d   Araya, Jun ^a   Kaneko, Yumi ^a   Nakayama, Katsutoshi ^a   Kishi, Kazuma ^c   Kuwano, Kazuyoshi ^a   more..

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Community acquired pneumonia; mixed infection; pneumococcal pneumonia; real time polymerase chain reaction

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN PARAINFLUENZA VIRUS 3; HUMAN RESPIRATORY SYNCYTIAL VIRUS A; IMMUNOASSAY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INTERMETHOD COMPARISON; JAPANESE (PEOPLE); KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MIXED INFECTION; MYCOPLASMA PNEUMONIAE; NONHUMAN; NOSE SMEAR; PATHOGENESIS; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RHINOVIRUS; SEROLOGY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; BACTERIUM; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; COMPARATIVE STUDY; EVALUATION STUDY; ISOLATION AND PURIFICATION; JAPAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; NASOPHARYNX; PNEUMONIA; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPUTUM; VERY ELDERLY; VIROLOGY; VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; JAPAN; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NASOPHARYNX; PNEUMONIA; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPUTUM; VIRUSES;

EID: 84978501332     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.1080/23744235.2016.1193788     Document Type: Article

References (36)

1. T.M.File Community-acquired pneumonia. Lancet. 2003;362:1991–2001.
2. Ministry of Health, Labour and Welfare. Vital Statistics in JAPAN – the latest trends – in Vital Statistics [Internet]; [cited 2016 May 9]. Available from:http://www.mhlw.go.jp/english/database/db-hw/vs01.html.
3. D.R.Park, V.L.Sherbin, M.S.Goodman,. The etiology of community-acquired pneumonia at an urban public hospital:influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis. 2001;184:268–277.
4. T.Ishida, T.Hashimoto, M.Arita,. Etiology of community-acquired pneumonia in hospitalized patients:a 3-year prospective study in Japan. Chest. 1998;114:1588–1593.
5. N.Miyashita, Y.Niki, T.Matsushima,. Community-acquired chlamydia pneumoniae pneumonia. Chest. 2000;117:615–616.
6. H.J.Durrington, C.Summers Recent changes in the management of community acquired pneumonia in adults. BMJ. 2008;336:1429–1433.
7. K.E.Templeton, S.A.Scheltinga, W.C.van den Eeden,. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–351.
8. A.Saito, S.Kohno, T.Matsushima,. Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother. 2006;12:63–69.
9. M.Angeles Marcos, M.Camps, T.Pumarola,. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther. 2006;11:351–359.
10. L.C.Jennings, T.P.Anderson, K.A.Beynon,. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63:42–48.
11. P.G.Charles, M.Whitby, A.J.Fuller,. The etiology of community-acquired pneumonia in Australia:why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis. 2008;46:1513–1521.
12. J.Johnstone, S.R.Majumdar, J.D.Fox,. Viral infection in adults hospitalized with community-acquired pneumonia:prevalence, pathogens, and presentation. Chest. 2008;134:1141–1148.
13. U.Hohenthal, R.Vainionpää, O.Meurman,. Aetiological diagnosis of community acquired pneumonia:utility of rapid microbiological methods with respect to disease severity. Scand J Infect Dis. 2008;40:131–138.
14. N.Johansson, M.Kalin, A.Tiveljung-Lindell,. Etiology of community-acquired pneumonia:increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50:202–209.
15. B.M.Diederen, M.M.Van Der Eerden, F.Vlaspolder,. Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia. Scand J Infect Dis. 2009;41:45–50.
16. S.H.Choi, S.B.Hong, G.B.Ko,. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186:325–332.
17. V.Luchsinger, M.Ruiz, E.Zunino,. Community-acquired pneumonia in Chile:the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–1006.
18. Y.F.Liu, Y.Gao, M.F.Chen,. Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China. BMC Infect Dis. 2013;13:309–319.
19. J.Karhu, T.I.Ala-Kokko, T.Vuorinen,. Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis. 2014;59:62–70.
20. M.Resti, A.Micheli, M.Moriondo,. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods:a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther. 2009;31:1266–1273.
21. M.Morozumi, E.Nakayama, S.Iwata,. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol. 2006;44:1440–1446.
22. K.Hamano-Hasegawa, M.Morozumi, E.Nakayama,. Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother. 2008;14:424–432.
23. T.Okada, M.Morozumi, H.Sakata,. A practical approach estimating etiologic agents using real-time PCR in pediatric inpatients with community-acquired pneumonia. J Infect Chemother. 2012;18:832–840.
24. T.Okada, M.Morozumi, T.Tajima,. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642–1649.
25. T.Kishimoto, S.Ando, K.Numazaki,. Assay of Chlamydia pneumoniae-specific IgM antibodies by ELISA method-reduction of non-specific reaction and resetting of serological criteria by measuring IgM antibodies. Jpn J Infect Dis. 2009;62:260–264.
26. I.C.Michelow, J.Lozano, K.Olsen,. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis. 2002;34:E1–E11.
27. N.Johansson, M.Kalin, C.G.Giske,. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;60:255–261.
28. W.C.Albrich, S.A.Madhi, P.V.Adrian,. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis. 2012;54:601–609.
29. K.Strålin, E.Törnqvist, M.S.Kaltoft,. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol. 2006;44:643–645.
30. R.Theerthakarai, W.El-Halees, M.Ismail,. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest. 2001;119:181–184.
31. K.Loens, L.Van Heirstraeten, S.Malhotra-Kumar,. Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol. 2009;47:21–31.
32. E.T.Fuse, H.Genma, M.Sato, Y.Suzuki, N.Koshimizu, K.Uemura,. Evaluation of the usefulness of a rapid immunochromatographic membrane test to detect Streptococcus pneumoniae antigen in the early diagnosis of pneumococcal respiratory tract infections and the relationship to the severity of pneumonia. Nihon Kokyuki Gakkai Zasshi. 2008;46:10–18 (Japanese Abstract in English).
33. W.C.Albrich, S.A.Madhi, P.V.Adrian,. Genomic load from sputum samples and nasopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults. J Clin Microbiol. 2014;52:4224–4229.
34. N.J.Gadsby, C.D.Russell, M.P.McHugh,. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62:817–823.
35. D.Lieberman, A.Shimoni, Y.Shemer-Avni,. Respiratory viruses in adults with community-acquired pneumonia. Chest. 2010;138:811–816.
36. O.Ruuskanen, E.Lahti, L.C.Jennings,. Viral pneumonia. Lancet. 2011;377:1264–1275.